Abstract
Through a modular ROMP (ring-opening metathesis polymerization) strategy, a random copolymer with anti-thrombotic activity and imaging capability has been constructed from RGD, rhodamine B and PEG modified norbornene monomers. As we expected, these tri-component polynorbornenes exhibit significant enhancement in anti-thrombotic efficacy and bioavailability in vivo.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Design*
-
Fibrinolytic Agents / chemistry*
-
Fibrinolytic Agents / pharmacology*
-
Molecular Imaging / methods*
-
Oligopeptides / chemistry
-
Polyethylene Glycols / chemistry
-
Polymerization
-
Polymers / chemistry*
-
Polymers / pharmacology*
-
Rhodamines / chemistry
Substances
-
Fibrinolytic Agents
-
Oligopeptides
-
Polymers
-
Rhodamines
-
Polyethylene Glycols
-
arginyl-glycyl-aspartic acid
-
rhodamine B